Published in Gene Therapy Weekly, September 5th, 2002
Cisplatin, a drug used for the treatment of cancer patients, can cause damage to auditory system cells when administered at high doses. The damage can lead to hearing loss. Scientists may have found a way to lessen the effects of cisplatin-induced ototoxicity, or auditory injury, with virus-based gene therapy, according to a report in Molecular Therapy.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.